Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,105,133
  • Shares Outstanding, K 71,391
  • Annual Sales, $ 4,230 K
  • Annual Income, $ -86,370 K
  • 60-Month Beta 1.71
  • Price/Sales 253.17
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade OCUL with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.10
  • Number of Estimates 4
  • High Estimate 0.00
  • Low Estimate -0.18
  • Prior Year -0.47
  • Growth Rate Est. (year over year) +78.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.11 +81.34%
on 10/28/20
16.66 -0.84%
on 11/25/20
+6.34 (+62.28%)
since 10/23/20
3-Month
7.14 +131.37%
on 09/04/20
16.66 -0.84%
on 11/25/20
+7.93 (+92.32%)
since 08/25/20
52-Week
3.14 +426.11%
on 11/26/19
16.66 -0.84%
on 11/25/20
+13.34 (+419.50%)
since 11/25/19

Most Recent Stories

More News
Look for Shares of Ocular Therapeut to Potentially Pullback after Yesterday's 5.43% Rise

Ocular Therapeut (NASDAQ:OCUL) traded in a range yesterday that spanned from a low of $15.55 to a high of $16.53. Yesterday, the shares gained 5.4%, which took the trading range above the 3-day high...

OCUL : 16.52 (+6.72%)
Ocular Therapeut Up 66.3% Since SmarTrend Uptrend Call (OCUL)

SmarTrend identified an Uptrend for Ocular Therapeut (NASDAQ:OCUL) on July 20th, 2020 at $9.02. In approximately 4 months, Ocular Therapeut has returned 66.28% as of today's recent price of $14.99.

OCUL : 16.52 (+6.72%)
Ocular Therapeutix(TM) to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced...

OCUL : 16.52 (+6.72%)
54.2% Return Seen to Date on SmarTrend Ocular Therapeut Call (OCUL)

SmarTrend identified an Uptrend for Ocular Therapeut (NASDAQ:OCUL) on July 20th, 2020 at $9.02. In approximately 4 months, Ocular Therapeut has returned 54.19% as of today's recent price of $13.90.

OCUL : 16.52 (+6.72%)
Watch for Ocular Therapeut to Potentially Pullback After Gaining 2.11% Yesterday

Ocular Therapeut (NASDAQ:OCUL) traded in a range yesterday that spanned from a low of $13.09 to a high of $13.66. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high...

OCUL : 16.52 (+6.72%)
Ocular Therapeutix(TM) To Present Data at the American Academy of Ophthalmology (AAO) 2020 Virtual Annual Meeting

Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced...

OCUL : 16.52 (+6.72%)
Ocular Therapeutix(TM) to Participate at Two Upcoming Investor Conferences

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced...

OCUL : 16.52 (+6.72%)
SmarTrend Watching for Potential Pullback in Shares of Ocular Therapeut After 6.58% Gain

Ocular Therapeut (NASDAQ:OCUL) traded in a range yesterday that spanned from a low of $11.89 to a high of $13.40. Yesterday, the shares gained 6.6%, which took the trading range above the 3-day high...

OCUL : 16.52 (+6.72%)
Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates (Revised)

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of 26.09% and 0.51%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

OCUL : 16.52 (+6.72%)
Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of 8.70% and 0.51%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

OCUL : 16.52 (+6.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular...

See More

Key Turning Points

2nd Resistance Point 17.39
1st Resistance Point 16.95
Last Price 16.52
1st Support Level 15.79
2nd Support Level 15.07

See More

52-Week High 16.66
Last Price 16.52
Fibonacci 61.8% 11.50
Fibonacci 50% 9.90
Fibonacci 38.2% 8.30
52-Week Low 3.14

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar